Polyphenols-Loaded Sericin Self-Assembling Nanoparticles: A Slow-Release for Regeneration by Tissue-Resident Mesenchymal Stem/Stromal Cells.
epigallocatechin gallate
mesenchymal stem/stromal cells
proanthocyanidins
quercetin
silk-sericin nanoparticles
tissue regeneration
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
21 Apr 2020
21 Apr 2020
Historique:
received:
19
03
2020
revised:
11
04
2020
accepted:
17
04
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
25
4
2020
Statut:
epublish
Résumé
Mesenchymal stem/stromal cells (MSCs) are a therapeutic target to promote tissue regeneration, mainly when oxidative stress-mediated damage is involved in disease pathogenesis. Here, slow-release silk sericin nanoparticles (SNPs) loaded with natural antioxidant polyphenols were developed to sustain regeneration by tissue-resident MSCs. SNPs were prepared by exploiting a self-assembly method with poloxamer and were loaded with proanthocyanidins (P), quercetin (Q) or epigallocatechin gallate (E). SNPs, with a diameter less than 150 nm, were able to encapsulate both hydrophilic (P and E) and hydrophobic (Q) drugs. A slow and controlled release was obtained from SNPs for all the actives in PBS, while in EtOH, Q and E showed a burst release but P did not. Kinetic models revealed lower diffusion of P than other biomolecules, probably due to the higher steric hindrance of P. The in vitro anti-oxidant, anti-elastase and anti-tyrosinase properties of SNPs were assessed: loading the P and E into SNPs preserved the in vitro biological activities whereas for Q, the anti-elastase activity was strongly improved. Moreover, all formulations promoted MSC metabolic activity over 72 h. Finally, SNPs exhibited a strong ability to protect MSCs from oxidative stress, which supports their potential use for regenerative purposes mediated by tissue-resident MSCs.
Identifiants
pubmed: 32326171
pii: pharmaceutics12040381
doi: 10.3390/pharmaceutics12040381
pmc: PMC7238282
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Interreg V-A Italy-Switzerland 2014-2020
ID : Project ID 637541
Références
Biosci Biotechnol Biochem. 1998 Jan;62(1):145-7
pubmed: 9501526
Biomed Pharmacother. 2019 Aug;116:108999
pubmed: 31146109
Drug Deliv. 2018 Nov;25(1):1103-1116
pubmed: 29742945
Soft Matter. 2018 Jan 24;14(4):546-557
pubmed: 29327746
Int J Biol Macromol. 2018 Nov;119:37-47
pubmed: 30048722
Adv Wound Care (New Rochelle). 2013 Oct;2(8):438-447
pubmed: 24688830
Biomacromolecules. 2015 Oct 12;16(10):3126-33
pubmed: 26348208
Cells. 2018 Oct 30;7(11):
pubmed: 30380806
Nutrients. 2015 Jul 07;7(7):5443-68
pubmed: 26198245
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:967-76
pubmed: 27612792
Cells. 2019 Aug 23;8(9):
pubmed: 31450843
J Enzyme Inhib Med Chem. 2019 Dec;34(1):279-309
pubmed: 30734608
Int J Biol Macromol. 2018 Oct 15;118(Pt A):792-799
pubmed: 29959012
J Control Release. 2019 Sep 10;309:11-24
pubmed: 31326462
Sci Technol Adv Mater. 2012 Jul 16;13(3):035010
pubmed: 27877498
Int J Pharm. 2017 Mar 30;520(1-2):86-97
pubmed: 28163224
Oxid Med Cell Longev. 2016;2016:2989076
pubmed: 27413419
Adv Drug Deliv Rev. 2013 Jan;65(1):21-3
pubmed: 22580334
J Microencapsul. 2015;32(3):255-72
pubmed: 25731821
Biochem Pharmacol. 2006 Nov 15;72(10):1268-78
pubmed: 16996034
Biol Pharm Bull. 1996 Jan;19(1):146-8
pubmed: 8820929
Int J Biol Macromol. 2019 Sep 15;137:545-553
pubmed: 31220499
Nutr Res Pract. 2011 Aug;5(4):281-7
pubmed: 21994521
Pharmaceutics. 2020 Feb 03;12(2):
pubmed: 32028579
Pharmacogn Rev. 2016 Jul-Dec;10(20):84-89
pubmed: 28082789
Integr Med Res. 2014 Mar;3(1):25-33
pubmed: 28664075
AAPS J. 2016 May;18(3):647-58
pubmed: 26935427
Tissue Eng Part B Rev. 2017 Dec;23(6):515-528
pubmed: 28490258
Waste Manag Res. 2012 Mar;30(3):217-24
pubmed: 21558082
ACS Appl Mater Interfaces. 2016 Mar;8(10):6577-85
pubmed: 26855027
Int J Pharm. 2019 Apr 5;560:175-190
pubmed: 30763681
J Agric Food Chem. 1999 Oct;47(10):4121-5
pubmed: 10552777
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Mater Sci Eng C Mater Biol Appl. 2016 Apr 1;61:940-52
pubmed: 26838924
Int J Mol Med. 2017 Apr;39(4):775-782
pubmed: 28290609
Molecules. 2019 Oct 28;24(21):
pubmed: 31661846
Eur J Pharm Biopharm. 2019 Apr;137:37-45
pubmed: 30772432
Int J Biol Macromol. 2013 Jul;58:47-56
pubmed: 23541552
Materials (Basel). 2017 Aug 23;10(9):
pubmed: 28832540
Eur J Pharm Biopharm. 2011 Oct;79(2):268-75
pubmed: 21596135
Biotechnol Adv. 2015 Dec;33(8):1855-67
pubmed: 26523781
Clin Exp Pharmacol Physiol. 2020 Mar;47(3):466-477
pubmed: 31675454
Acta Biomater. 2017 Jun;55:262-270
pubmed: 28365481
Int J Biol Macromol. 2003 Mar;32(1-2):36-42
pubmed: 12719130
Int J Pharm. 2017 Feb 25;518(1-2):167-176
pubmed: 28011344
Int J Pharm. 2018 Feb 15;537(1-2):48-56
pubmed: 29229512
Pharm Biol. 2016 Sep;54(9):1865-72
pubmed: 26912420
Nanotechnology. 2009 Sep 2;20(35):355101
pubmed: 19671963
Cancers (Basel). 2018 Jul 20;10(7):
pubmed: 30037052